Open house Arzneimittelrabattverträge zum Wirkstoff Darbepoetin alfa, ATC B03XA02

TENDER DESCRIPTION

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse offers all interested pharmaceutical companies, without a selection decision, discount agreements with the above-mentioned active ingredient. The agreements are concluded within the framework of an "Open House model". The contracts offered are not exclusive; contracts with all market participants (pharmaceutical companies) are desired by AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse. In the open-house model, uniform conditions apply to all participants. Contract content, terms and conditions and access procedures are uniform—no individual negotiations are conducted. The contract terms are a maximum of 24 months; the earliest contract start date is 01.12.2026. All contracts end no later than 24 months after the day of the earliest contract start date, regardless of the date on which the respective contract is concluded. Accession or conclusion of a contract may be made within the 24-month period on the first day of each month. There is a right of termination, in each case 6 weeks before the end of the month, in accordance with the provisions of the contract. Further information on the options for termination is included in…

TENDER BRIEF

TENDER DOCUMENTS